Susanna Ranta

Publikationer
Populärvetenskap och samverkan

Artiklar

Article: ACTA PAEDIATRICA, INTERNATIONAL JOURNAL OF PAEDIATRICS. 2024;113(8):1974-1976
Intensive care in children with non-Hodgkin lymphoma in Sweden
Ranta S; Broman LM; Mellgren K; Noren-Nystroem U; Svahn J; Toernudd L; Heyman M; Harila A
Article: THROMBOSIS AND HAEMOSTASIS. 2024;124(01):32-39
Clinical Implications of Discrepancy between One-Stage Clotting and Chromogenic Factor IX Activity in Hemophilia B
Schmidt DE; Truedsson A; Stralfors A; Hojbjerg JA; Soutari N; Holmstrom M; Ranta S; Letelier A; Bowyer A; Ljung R; Antovic J; Bruzelius M
Article: ACTA ONCOLOGICA. 2023;62(12):1723-1731
Impact of body mass index on outcome and treatment-related toxicity in young adults with acute lymphoblastic leukemia
Egnell C; Hallbook H; Heyman M; Wartiovaara-Kautto U; Quist-Paulsen P; Schmiegelow K; Griskevicius L; Palk K; Toft N; Overgaard UM; Harila A; Ranta S
Article: HAEMOPHILIA. 2023;29(5):1291-1298
Dilemmas on emicizumab in children with haemophilia A: A survey of strategies from PedNet centres
Ranta S; Motwani J; Blatny J; Buehrlen M; Carcao M; Chambost H; Escuriola C; Fischer K; Kartal-Kaess M; de Kovel M; Kenet G; Male C; Nolan B; d'Oiron R; Olivieri M; Zapotocka E; Andersson NG; Koenigs C
Article: HAEMOPHILIA. 2023;29(4):987-996
No difference in quality of life between persons with severe haemophilia A and B
Kihlberg K; Baghaei F; Bruzelius M; Funding E; Holme PA; Lassila R; Nummi V; Ranta S; Andersson NG; Berntorp E; Astermark J
Article: EUROPEAN JOURNAL OF HAEMATOLOGY. 2022;109(6):656-663
Changes in body mass index during treatment of childhood acute lymphoblastic leukemia with the Nordic ALL2008 protocol
Egnell C; Narhinen H; Merker A; Jonsson OG; Lepik K; Niinimaki R; Schmiegelow K; Stabell N; Klug Albertsen B; Vaitkeviciene G; Ranta S; Harila-Saari A
Article: HAEMOPHILIA. 2022;28(6):1054-1061
Long-term joint outcomes in adolescents with moderate or severe haemophilia A
Schmidt DE; Michalopoulou A; Fischer K; Motwani J; Andersson NG; Pergantou H; Ranta S
Article: ACTA PAEDIATRICA, INTERNATIONAL JOURNAL OF PAEDIATRICS. 2022;111(11):2235-2241
High need for intensive care in paediatric acute myeloid leukaemia: A population-based study
Ranta S; Broman LM; Abrahamsson J; Karlsson L; Noren-Nystrom U; Palle J; Svahn JE; Tornudd L; Heyman M; Harila-Saari A
Article: HAEMATOLOGICA. 2022;107(10):2318-2328
Acute central nervous system toxicity during treatment of pediatric acute lymphoblastic leukemia: phenotypes, risk factors and genotypes
Anastasopoulou S; Nielsen RL; Als-Nielsen B; Banerjee J; Eriksson MA; Helenius M; Heyman MM; Johannsdottir IM; Jonsson OG; MacGregor S; Mateos MK; Mayoh C; Mikkel S; Myrberg IH; Niinimaeki R; Schmiegelow K; Taskinen M; Vaitkeviciene G; Warnqvist A; Wolthers B; Harila-Saari A; Ranta S
Article: BRITISH JOURNAL OF HAEMATOLOGY. 2022;199(1):117-121
A survey on thromboprophylaxis and coagulation assessment in children and young adults with acute lymphoblastic leukaemia (ALL) in the Nordic and Baltic countries: Different practices of assessment and management
Andersson NG; Rathe M; Molle I; Jarvis KB; Hoffmann M; Huurre A; Joelsson J; Albertsen BK; Lohi O; Langstrom S; Overgaard U; Trakymiene SS; Vepsalainen K; Vogt H; Ranta S
Article: THROMBOSIS RESEARCH. 2022;217:22-32
Factor IX antibodies and tolerance in hemophilia B in the Nordic countries - The impact of F9 variants and complications
Kihlberg K; Baghaei F; Bruzelius M; Funding E; Holme PA; Lassila R; Martin M; Nummi V; Ranta S; Strandberg K; Andersson NG; Berntorp E; Astermark J
Article: EJHAEM. 2022;3(3):754-763
Cerebral sinovenous thrombosis and asparaginase re-exposure in patients aged 1-45 years with acute lymphoblastic leukaemia: A NOPHO ALL2008 study
Skipper MT; Rank CU; Jarvis KB; Lynggaard LS; Andres-Jensen L; Quist-Paulsen P; Semaskeviciene R; Hallbook H; Waitiovaara-Kautto U; Ranta S; Trakymiene S; Abrahamsson J; Huttunen P; Albertsen BK; Schmiegelow K; Tuckuviene R
Article: PEDIATRIC BLOOD AND CANCER. 2022;69(7):e29745
Does minimal central nervous system involvement in childhood acute lymphoblastic leukemia increase the risk for central nervous system toxicity?
Anastasopoulou S; Harila-Saari A; Als-Nielsen B; Eriksson MA; Heyman M; Johannsdottir IM; Marquart HV; Niinimaki R; Pronk CJ; Schmiegelow K; Vaitkeviciene G; Thastrup M; Ranta S
Article: BRITISH JOURNAL OF HAEMATOLOGY. 2022;196(5):1239-1247
Obesity as a predictor of treatment-related toxicity in children with acute lymphoblastic leukaemia
Egnell C; Heyman M; Jonsson OG; Raja RA; Niinimaki R; Albertsen BK; Schmiegelow K; Stabell N; Vaitkeviciene G; Lepik K; Harila-Saari A; Ranta S
Article: BLOOD ADVANCES. 2022;6(1):138-147
Asparaginase enzyme activity levels and toxicity in childhood acute lymphoblastic leukemia: a NOPHO ALL2008 study
Lynggaard LS; Rank CU; Hansen SN; Hojfeldt SG; Henriksen LT; Jarvis KB; Ranta S; Niinimaki R; Harila-Saari A; Wolthers BO; Frandsen TL; Heyman M; Schmiegelow K; Albertsen BK
Article: PEDIATRIC CRITICAL CARE MEDICINE. 2021;22(12):1050-1060
ICU Admission in Children With Acute Lymphoblastic Leukemia in Sweden: Prevalence, Outcome, and Risk Factors
Ranta S; Broman LM; Abrahamsson J; Berner J; Flaring U; Hed Myrberg I; Kalzen H; Karlsson L; Mellgren K; Nilsson A; Noren-Nystrom U; Palle J; von Schewelov K; Svahn JE; Tornudd L; Heyman M; Harila-Saari A
Article: CANCERS. 2021;13(10):2333
Pharmacogenetics of the Central Nervous System-Toxicity and Relapse Affecting the CNS in Pediatric Acute Lymphoblastic Leukemia
Sagi JC; Gezsi A; Egyed B; Jakab Z; Benedek N; Attarbaschi A; Koehrer S; Sipek J; Winkowska L; Zaliova M; Anastasopoulou S; Wolthers BO; Ranta S; Szalai C; Kovacs GT; Semsei AF; Erdelyi DJ
Article: HAEMOPHILIA. 2021;27(3):366-374
Treatment outcomes in persons with severe haemophilia B in the Nordic region: The B-NORD study
Kihlberg K; Baghaei F; Bruzelius M; Funding E; Holme PA; Lassila R; Nummi V; Ranta S; Osooli M; Berntorp E; Astermark J
Article: HAEMOPHILIA. 2021;27(3):392-397
Correction of haemostasis can be reduced to four days for CVAD implantation in severe haemophilia A patients: Data from the PedNet study group
Minna K; Anne M; Beatrice N; Rainer K; Susanna R
Article: JOURNAL OF PEDIATRIC HEMATOLOGY/ONCOLOGY. 2021;43(4):e564-e566
Asymptomatic Right Atrial Thrombosis After Acute Lymphoblastic Leukemia Treatment
Jarvis KB; Andersson NG; Giertz M; Jarvela L; Lindinger O; Langstrom S; Niinimaki R; Palmu S; Trakymiene SS; Tuckuviene R; Vepsalainen K; Ranta S; Frisk T
Article: JOURNAL OF PEDIATRIC HEMATOLOGY/ONCOLOGY. 2021;43(2):e272-e275
Extracorporeal Membrane Oxygenation Support in Children With Hematologic Malignancies in Sweden
Ranta S; Kalzen H; Nilsson A; von Schewelov K; Broman LM; Berner J; Flaring U; Noren-Nystrom U; Svahn JE; Palle J; Tornudd L; Karlsson L; Mellgren K; Abrahamsson J; Harila-Saari A
Article: THROMBOSIS RESEARCH. 2020;196:15-20
Polygenic risk score-analysis of thromboembolism in patients with acute lymphoblastic leukemia
Jarvis KB; Nielsen RL; Gupta R; Hede FD; Huttunen P; Jonsson OG; Rank CU; Ranta S; Saks K; Trakymiene SS; Tuckuviene R; Tulstrup M; Ruud E; Schmiegelow K; LeBlanc M
Article: EUROPEAN JOURNAL OF HAEMATOLOGY. 2020;105(6):797-807
Impact of body mass index on relapse in children with acute lymphoblastic leukemia treated according to Nordic treatment protocols
Egnell C; Ranta S; Banerjee J; Merker A; Niinimaki R; Lund B; Mogensen PR; Jonsson OG; Vaitkeviciene G; Lepik K; Forslund A; Heyman M; Harila-Saari A
Article: JOURNAL OF THROMBOSIS AND HAEMOSTASIS. 2020;18(10):2582-2589
Management and outcomes of newborns at risk for inherited antithrombin deficiency
Chaireti R; Tronnhagen I; Bremme K; Ranta S
Article: EUROPEAN JOURNAL OF PAEDIATRIC NEUROLOGY. 2020;27:72-77
Seizures during treatment of childhood acute lymphoblastic leukemia: A population-based cohort study
Anastasopoulou S; Heyman M; Eriksson MA; Niinimaki R; Taskinen M; Mikkel S; Vaitkeviciene GE; Johannsdottir IM; Myrberg IH; Jonsson OG; Als-Nielsen B; Schmiegelow K; Banerjee J; Ranta S; Harila-Saari A
Article: RESEARCH AND PRACTICE IN THROMBOSIS AND HAEMOSTASIS. 2020;4(5):866-871
Pulmonary embolism in acute lymphoblastic leukemia - An observational study of 1685 patients treated according to the NOPHO ALL2008 protocol
Tuckuviene R; Bjerg CL; Jonsson OG; Langstrom S; Rank CU; Ranta S; Saks K; Trakymiene SS; Ruud E
Article: PEDIATRIC BLOOD AND CANCER. 2020;67(2):e27999
The spectrum of acute central nervous system symptoms during the treatment of childhood acute lymphoblastic leukaemia
Banerjee J; Niinimaki R; Lahteenmaki P; Myrberg IH; Arola M; Riikonen P; Lonnqvist T; Palomaki M; Ranta S; Harila-Saari A; Taskinen M
Article: THROMBOSIS RESEARCH. 2019;184:92-98
Candidate single nucleotide polymorphisms and thromboembolism in acute lymphoblastic leukemia - A NOPHO ALL2008 study
Jarvis KB; LeBlanc M; Tulstrup M; Nielsen RL; Albertsen BK; Gupta R; Huttunen P; Jonsson OG; Rank CU; Ranta S; Ruud E; Saks K; Trakymiene SS; Tuckuviene R; Schmiegelow K
Article: HAEMATOLOGICA. 2019;104(10):2100-2106
Mode of delivery in hemophilia: vaginal delivery and Cesarean section carry similar risks for intracranial hemorrhages and other major bleeds
Andersson NG; Chalmers EA; Kenet G; Ljung R; Makipernaa A; Chambost H; Altisent Roca C; Alvarez Roman MT; Buehrlen M; van den Berg HM; Chalmers E; Chambost H; Rosa Cid A; Claeyssens S; Escuriola C; Fischer K; Van Geet C; Kobelt R; Koenigs C; Kurnik K; Liesner R; Ljung R; Makipernaa A; Molinari A; Muntean W; Nolan B; Oldenburg J; Perez Garrido R; Platokouki H; Rafowicz A; Ranta S; Santagostino E; Mancuso ME; Bonomi AB; Mikkelsen TS; Thomas A; Kenet G; Williams M; Carcao M; Rivard G
Article: PEDIATRIC BLOOD AND CANCER. 2019;66(5):e27594
Posterior reversible encephalopathy syndrome in children with acute lymphoblastic leukemia: Clinical characteristics, risk factors, course, and outcome of disease
Anastasopoulou S; Eriksson MA; Heyman M; Wang C; Niinimaki R; Mikkel S; Vaitkeviciene GE; Johannsdottir IM; Myrberg IH; Jonsson OG; Als-Nielsen B; Schmiegelow K; Banerjee J; Harila-Saari A; Ranta S
Article: THROMBOSIS AND HAEMOSTASIS. 2018;118(8):1390-1396
Haematopoietic Stem Cell Transplantation in Children Shifts the Coagulation System towards a Pro-Coagulant State
Langstroem S; Koskenvuo M; Huttunen P; Lassila R; Taskinen M; Ranta S; Heikinheimo M; Makipernaa A
Article: PEDIATRIC BLOOD AND CANCER. 2017;64(12)
Presenting features and imaging in childhood acute myeloid leukemia with central nervous system involvement
Ranta S; Palomaki M; Levinsen M; Taskinen M; Abrahamsson J; Hasle H; Jahnukainen K; Heyman M; Harila-Saari A
Article: PEDIATRIC BLOOD AND CANCER. 2017;64(10)
Hypertriglyceridemia during asparaginase treatment in children with acute lymphoblastic leukemia correlates with antithrombin activity in adolescents
Persson L; Harila-Saari A; Myrberg IH; Heyman M; Nilsson A; Ranta S
Article: HAEMOPHILIA. 2017;23(4):e276-e281
The impact of clinical practice on the outcome of central venous access devices in children with haemophilia
Khair K; Ranta S; Thomas A; Lindvall K
Article: THROMBOSIS RESEARCH. 2017;152:64-68
Venous thrombosis in children and adolescents with Hodgkin lymphoma in Sweden
Schonning A; Karlen J; Frisk T; Heyman M; Svahn JE; Ora I; Kawan L; Holmqvist B-M; Bjorklund C; Harila-Saari A; Ranta S
Article: PEDIATRIC BLOOD AND CANCER. 2017;64(1):64-70
Role of neuroimaging in children with acute lymphoblastic leukemia and central nervous system involvement at diagnosis
Ranta S; Palomaki M; Levinsen M; Taskinen M; Abrahamsson J; Mellgren K; Niinimaeki R; Schmiegelow K; Heyman M; Harila-Saari A
Article: JOURNAL OF THROMBOSIS AND HAEMOSTASIS. 2016;14(3):485-494
Prospective study of thromboembolism in 1038 children with acute lymphoblastic leukemia: a Nordic Society of Pediatric Hematology and Oncology (NOPHO) study
Tuckuviene R; Ranta S; Albertsen BK; Andersson NG; Bendtsen MD; Frisk T; Gunnes MW; Helgestad J; Heyman MM; Jonsson OG; Maekipernaa A; Pruunsild K; Tedgard U; Trakymiene SS; Ruud E
Article: JOURNAL OF THROMBOSIS AND HAEMOSTASIS. 2015;13(6):1010-1018
Recurrent venous thromboembolism in anticoagulated patients with cancer: management and short-term prognosis
Schulman S; Zondag M; Linkins L; Pasca S; Cheung YW; De Sancho M; Gallus A; Lecumberri R; Molnar S; Ageno W; Le Gal G; Falanga A; Hulegardh E; Ranta S; Kamphuisen P; Debourdeau P; Rigamonti V; Ortel TL; Lee A
Article: PEDIATRIC BLOOD AND CANCER. 2015;62(6):951-956
Detection of Central Nervous System Involvement in Childhood Acute Lymphoblastic Leukemia by Cytomorphology and Flow Cytometry of the Cerebrospinal Fluid
Ranta S; Nilsson F; Harila-Saari A; Saft L; Tani E; Soderhall S; Porwit A; Hultdin M; Noren-Nystrom U; Heyman M
Article: BRITISH JOURNAL OF HAEMATOLOGY. 2015;168(4):547-552
Cerebral sinus venous thromboses in children with acute lymphoblastic leukaemia - a multicentre study from the Nordic Society of Paediatric Haematology and Oncology
Ranta S; Tuckuviene R; Makipernaa A; Albertsen BK; Frisk T; Tedgard U; Jonsson OG; Pruunsild K; Andersson NG; Gunnes MW; Trakymiene SS; Frandsen T; Heyman M; Ruud E; Helgestad J
Article: THROMBOSIS RESEARCH. 2014;133(3):340-344
Venous thromboembolism in children with cancer - A population-based cohort study
Walker AJ; Grainge MJ; Card TR; West J; Ranta S; Ludvigsson JF
Article: EUROPEAN ARCHIVES OF PAEDIATRIC DENTISTRY : OFFICIAL JOURNAL OF THE EUROPEAN ACADEMY OF PAEDIATRIC DENTISTRY. 2013;14(5):339-343
Oral health care in children with haemophilia in Helsinki, Finland.
Rajantie H; Alapulli H; Mäkipernaa A; Ranta S
Article: BLOOD COAGULATION AND FIBRINOLYSIS. 2013;24(7):749-756
Antithrombin deficiency after prolonged asparaginase treatment in children with acute lymphoblastic leukemia
Ranta S; Heyman MM; Jahnukainen K; Taskinen M; Saarinen-Pihkala UM; Frisk T; Soderhall S; Petrini P; Makipernaa AM-T
Article: HAEMOPHILIA. 2013;19(2):200-205
Hypercalciuria and kidney function in children with haemophilia
Ranta S; Valta H; Viljakainen H; Makitie O; Makipernaa A
Article: HAEMOPHILIA. 2012;18(6):955-961
Peripheral quantitative computed tomography (pQCT) reveals alterations in the three-dimensional bone structure in children with haemophilia
Ranta S; Viljakainen H; Makipernaa A; Makitie O
Article: HAEMOPHILIA. 2012;18(4):521-526
MRI after removal of central venous access device reveals a high number of asymptomatic thromboses in children with haemophilia
Ranta S; Kalajoki-Helmio T; Pouttu J; Makipernaa A
Article: BRITISH JOURNAL OF HAEMATOLOGY. 2011;153(3):364-371
Hypercalciuria in children with haemophilia suggests primary skeletal pathology
Ranta S; Viljakainen H; Makipernaa A; Makitie O
Article: BMC MEDICAL GENETICS. 2009;10:54
A mitotic recombination map proximal to the APC locus on chromosome 5q and assessment of influences on colorectal cancer risk
Howarth K; Ranta S; Winter E; Teixeira A; Schaschl H; Harvey JJ; Rowan A; Jones A; Spain S; Clark S; Guenther T; Stewart A; Silver A; Tomlinson I
Article: HUMAN MUTATION. 2004;23(4):300-305
Variant late infantile neuronal ceroid lipofuscinosis in a subset of Turkish patients is allelic to northern epilepsy
Ranta S; Topcu M; Tegelberg S; Tan H; Üsübütün A; Saatci I; Dufke A; Enders H; Pohl K; Alembik Y; Mitchell WA; Mole SE; Lehesjoki AE
Article: EUROPEAN JOURNAL OF PAEDIATRIC NEUROLOGY. 2001;5 Suppl A:21-27
Turkish variant late infantile neuronal ceroid lipofuscinosis (CLN7) may be allelic to CLN8.
Mitchell WA; Wheeler RB; Sharp JD; Bate SL; Gardiner RM; Ranta US; Lonka L; Williams RE; Lehesjoki AE; Mole SE
Article: HUMAN MOLECULAR GENETICS. 2000;9(11):1691-1697
The neuronal ceroid lipofuscinosis CLN8 membrane protein is a resident of the endoplasmic reticulum
Lonka L; Kyttälä A; Ranta S; Jalanko A; Lehesjoki AE
Article: EUROPEAN JOURNAL OF HUMAN GENETICS. 2000;8(5):381-384
Positional cloning and characterisation of the human DLGAP2 gene and its exclusion in progressive epilepsy with mental retardation
Ranta S; Zhang YH; Ross B; Takkunen E; Hirvasniemi A; de la Chapelle A; Gilliam TC; Lehesjoki AE
Article: NATURE GENETICS. 1999;23(2):233-236
The neuronal ceroid lipofuscinoses in human EPMR and mnd mutant mice are associated with mutations in CLN8
Ranta S; Zhang YH; Ross B; Lonka L; Takkunen E; Messer A; Sharp J; Wheeler R; Kusumi K; Mole S; Liu WC; Soares MB; Bonaldo MD; Hirvasniemi A; de la Chapelle A; Gilliam TC; Lehesjoki AE
Article: GENOME RESEARCH. 1997;7(9):887-896
High-resolution mapping and transcript identification at the progressive epilepsy with mental retardation locus on chromosome 8p
Ranta S; Lehesjoki AE; Bonaldo MD; Knowles JA; Hirvasniemi A; Ross B; deJong PJ; Soares MB; delaChapelle A; Gilliam TC
Article: GENOME RESEARCH. 1996;6(5):351-360
Genetic and physical mapping of the progressive epilepsy with mental retardation (EPMR) locus on chromosome 8p
Ranta S; Lehesjoki AE; Hirvasniemi A; Weissenbach J; Ross B; Leal SM; delaChapelle A; Gilliam TC
Article: NEUROMUSCULAR DISORDERS. 1995;5(3):221-225
MUSCLE-EYE-BRAIN DISEASE AND FUKUYAMA TYPE CONGENITAL MUSCULAR-DYSTROPHY ARE NOT ALLELIC
RANTA S; PIHKO H; SANTAVUORI P; TAHVANAINEN E; DELACHAPELLE A
Article: GENOMICS. 1995;26(2):290-293
CORNEA PLANA CONGENITA GENE ASSIGNED TO THE LONG ARM OF CHROMOSOME-12 BY LINKAGE ANALYSIS
TAHVANAINEN E; FORSIUS H; KARILA E; RANTA S; EEROLA M; WEISSENBACH J; SISTONEN P; DELACHAPELLE A
Visa fler

Alla övriga publikationer

Review: ACTA PAEDIATRICA, INTERNATIONAL JOURNAL OF PAEDIATRICS. 2024;113(7):1483-1495
Successful treatment of paediatric refractory Hodgkin lymphoma with immunotherapy - A case report and literature review
Mogensen N; Cananau C; Ranta S; Karlen J; Kwiecinska A; Baecklund F
Letter: CLINICAL CHEMISTRY AND LABORATORY MEDICINE. 2023;61(12):e248-e250
Laboratory response to paradigm change in hemophilia treatment How to monitor patients simultaneously treated with emicizumab and factor VIII concentrate?
Lambert MS; Bruzelius M; Soutari NMH; Ranta S; Antovic JPP
Letter: JOURNAL OF THROMBOSIS AND HAEMOSTASIS. 2023;21(3):700-703
Different inhibitor incidence for individual factor VIII concentrates in 1076 previously untreated patients with severe hemophilia A: data from the PedNet cohort
Fischer K; Carcao M; Male C; Ranta S; Pergantou H; Kenet G; Kartal-Kaess M; Koenigs C; Carvalho M; Alvarez MT; Brakenhoff T; Chambost H; van den Berg HM
Letter: HAEMOPHILIA. 2023;29(1):377-381
Real-world prophylactic usage of recombinant factor IX Fc in Sweden: A report from the Swedish National Registry for bleeding disorders
Olsson A; Westesson LM; Baghaei F; Holmstrom M; Olsson E; Magnusson M; Ranta S; Astermark J; Andersson NGG; Thanner J; Szamosi J; Daoura L; Sennfaelt K
Meeting abstract: BLOOD. 2022;140:6033-6034
High-Dose Methotrexate-Related Toxicity in Children with Acute Lymphoblastic Leukemia
Gustafsson CE; Frederiksen GG; Thorwaldson J; Heyman M; Harila-Saari A; Ranta S
Meeting abstract: BLOOD. 2020;136:30
The Association between Asparaginase Enzyme Activity Levels and Toxicities in Childhood Acute Lymphoblastic Leukaemia in the NOPHO ALL2008 Protocol
Lynggaard LS; Moeller L; Rank CU; Hojfeldt SG; Henriksen LT; Jarvis KB; Ranta S; Niinimaki R; Harila-Saari A; Wolthers BO; Heyman M; Frandsen TL; Schmiegelow K; Albertsen BK
Letter: BRITISH JOURNAL OF HAEMATOLOGY. 2020;190(2):e101-e104
Long-term follow-up of neonatal intracranial haemorrhage in children with severe haemophilia
Andersson NG; Wu R; Carcao M; Claeyssens-Donadel S; Kobelt R; Liesner R; Makipernaa A; Ranta S; Ljung R
Meeting abstract: BLOOD. 2018;132:1193
Immune Tolerance Induction for FIX Inhibitors Using Combined B and T Cell Immune Modulation Therapy in Severe Hemophilia B
Abajas YL; Monahan PE; Nielsen B; Petrini P; Ranta S; Allen GA; Horneff S; Martensson A; Oldenburg J; Ljung R
Meeting abstract: BLOOD. 2018;132:2472
99.3% of Inhibitors in Severe Hemophilia a Develop before Exposure Day 75. Time to Change Definition of Previously Treated Patients; Data from 1038 Patients with Severe Hemophilia a of the Pednet Registry
Van den Berg M; Fischer K; Santagostino E; Chambost H; Kurnik K; Kenet G; Male C; Rafowicz A; Platokouki H; Ranta S; Van Geet C; Oldenburg J; Liesner R; Claeyssens S; Gretenkort-Andersson N; Makipernaa A; Mikkelsen TS; Carcao M; Nolan B; Chalmers L; Cid AR; Alvarez-Roman T; Altisent C; Rivard G; Molinari C; Buehrlen M; Kobelt R; Escuriola C; Carvalho M; Koenigs C; Williams M; Ljung R
Meeting abstract: BLOOD. 2018;132:143
Single Nucleotide Polymorphisms and Thromboembolism in Acute Lymphoblastic Leukemia - a NOPHO ALL2008 Study
Jarvis KB; Le Blanc M; Tulstrup M; Ruud E; Tuckuviene R; Ranta S; Schmiegelow K
Letter: HAEMOPHILIA. 2018;24(5):e380-e383
Perioperative haemostasis in children with haemophilia and inhibitors during central venous catheter surgery: The Karolinska model
Hagglof H; Magnusson M; Petrini P; Frisk T; Ranta S
Letter: THROMBOSIS RESEARCH. 2016;141:66-68
Postoperative cerebral bleeding in a boy with suspected mild deficiency of fibrinogen and FXIII
Ranta S; Blomback M; Magnusson M; He S
Meeting abstract: BLOOD. 2012;120(21):2241
Risk of Thrombosis with Different Approaches to Central Venous Access During Acquired Asparaginase Related Antithrombin Deficiency in Children with Leukemia
Ranta S; Heyman M; Jahnukainen K; Taskinen M; Saarinen-Pihkala UM; Frisk T; Soderhall S; Petrini P; Makipernaa A
Letter: HAEMOPHILIA. 2012;18(4):e349-e351
Identical but different: haemophilia B in monozygotic twins with inhibitor in one brother and subsequent successful immune tolerance induction.
Ranta S; Verbruggen B; Wikström A; Mäkipernaa A
Letter: HAEMOPHILIA. 2011;17(5):e833-e834
Successful eradication of inhibitor of late recurrence and other high risk prognostic factors in a patient with severe haemophilia A.
Ranta S; Koskinen S; Mäkipernaa A
Review: DUODECIM; LAAKETIETEELLINEN AIKAKAUSKIRJA. 2002;118(15):1551-1558
[Northern epilepsy and the gene error behind it].
Ranta S; Hirvasniemi A; Herva R; Haltia M; Lehesjoki A-E
Review: ADVANCES IN GENETICS. 2001;45:123-140
Studies of homogenous populations: CLN5 and CLN8.
Ranta S; Savukoski M; Santavuori P; Haltia M
Published conference paper: NEUROLOGICAL SCIENCES. 2000;21(3):S43-S47
Northern epilepsy, a new member of the NCL family
Ranta S; Lehesjoki AE
Editorial comment: CYTOGENETIC AND GENOME RESEARCH. 1995;68(3-4):148-155
REPORT OF THE 2ND INTERNATIONAL WORKSHOP ON HUMAN-CHROMOSOME-8 MAPPING 1994
SPURR NK; BLANTON S; BOOKSTEIN R; CLARKE R; COTTINGHAM R; DAIGER S; DRAYNA D; FABER P; HORRIGAN S; KAS K; KIRCHGESSNER C; KUMAR S; LEACH RJ; LUEDECKE HJ; NAKAMURA Y; PEBUSQUE MJ; RANTA S; SIM E; SULLIVAN LS; TAKLE L; VANCE J; WAGNER M; WELLS D; WESTBROOK C; YAREMKO L; ZALETAYEV D; ZUFFARDI O; WOOD S

Artiklar

Alla övriga publikationer

Nyheter från KI

Kalenderhändelser från KI